Clinical Trial Update: Recombinant Human Granulocyte Macrophage Colony Stimulating Factor(rhGM-CSF) Treating Oral Mucositis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating recombinant human GM-CSF (rhGM-CSF) for treating oral mucositis in patients with nasopharyngeal cancer; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Cancer

Drugs mentioned

• recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Wei LUO | Conditions: Nasopharyngeal Cancers | Phase 2 | Status: UNKNOWN